HDAC Inhibitor Augmentation to Clozapine
NCT03263533
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
PIs were unable to recruit any participants
Conditions
Schizophrenia
Interventions
DRUG:
Vorinostat Oral Capsule Group 1
DRUG:
Vorinostat Oral Capsule Group 2
Sponsor
Virginia Commonwealth University